• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Real-time messaging connects eye-care practices to patients

Article

San Francisco-A practice-to-patient communication service from Smile Reminder helps vision-care providers communicate directly with patients by automatically sending text or e-mail messages.

San Francisco-A practice-to-patient communication service from Smile Reminder helps vision-care providers communicate directly with patients by automatically sending text or e-mail messages.

Messages include appointment reminders, birthday greetings, e-surveys, and newsletters to returning patients and special promotions for new prospects. The messages are customizable and include branding elements such as a company’s logo and photographs, contact information, physician’s signature, and links to the practice’s Web site.

“Everybody is busy, doctors and patients included,” said Jim Higgins, chief executive officer, Smile Reminder. “Our technology bridges the gap to keep communication flowing and relationships vibrant.”

Related Videos
 John Bladen, MBBS, BSc, MRCS, PGCert, PhD, FRCOphth, consultant ophthalmologist and oculoplastic surgeon, King's College Hospital NHS Foundation Trust, London, UK, speaks with Ophthalmology Times Europe's® Caroline Richards
rande, CFP, and John S. Grande, CFP, of Grande Financial Services, continue their discussion with Ophthalmology Times®' Sheryl Stevenson
What keeps you up at night?
S.K. Steven Houston III, MD, discusses retina innovations in use in his practice, including the NGENUITY 1.4 upgrade from Alcon
Caesar Luo, MD, shares his key take-aways on diabetic retinopathy progression in anti-VEGF versus FA implant
© 2024 MJH Life Sciences

All rights reserved.